We are committed to supporting your growing need for high‑quality peptides and oligonucleotides - key components in life‑saving therapies. To better serve your development and commercial programs, we are expanding our global manufacturing network with a new site, Sisslerfeld, in Switzerland. This added capacity ensures reliable, future‑proof supply of TIDES to you and the patients who depend on them. Sisslerfeld will significantly strengthen large‑scale manufacturing capabilities, create new opportunities for collaboration, and further support the growth of the life sciences cluster in Northwestern Switzerland.